Latest Breaking News On - Sylvie berrebi frazer hall - Page 1 : comparemela.com

Availability of Preparatory Documents for the Combined General Meeting of May 15, 2024

Strasbourg, France, April 24, 2024, 5:45 p.m. CET - Transgene , a biotech company that designs and develops virus-based immunotherapies, announced that the documentation related to the Combined.

Transgene Announces Financial Calendar for 2024

Oxurion NV: Oxurion Announces Upcoming Pre-Clinical Data Presentation on THR-687 for the Treatment of Diabetic Macular Edema at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Leuven, BELGIUM, Boston, MA, US - 11 April 2022 - 7.00 AM CET - Oxurion NV(Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with a

Oxurion NV: Information on the Total Number of Voting Rights (Denominator) following EUR > 10 million Private Placement and conversion notice from NEGMA

Oxurion has successfully raised EUR >10 million from leading US and European healthcare investors in a private equity placement and Negma Group has converted 240 convertible bonds in Oxurion resulting

Oxurion to Participate in Needham Virtual Healthcare Conference

Press release content from Globe Newswire. The AP news staff was not involved in its creation.